Pridiktiv has been acquired by Corilus

The shareholders and founders of Pridiktiv NV have sold the company to Corilus.

Pridiktiv specializes in mobile cloud-based healthcare solutions that turn big and raw patient data into user-friendly and actionable data to support day-to-day health/elderly care. Its into.care software is a revolutionary and comprehensive suite covering basic medical/care patient administration, work planning, medication, accounting and management reporting.

Corilus is the Belgian market leader in software and ICT solutions for elderly care. It develops smart and efficient systems and connects healthcare providers, patients and stakeholders. Corilus’ software has applications for general practitioners, pharmacists, physiotherapists, midwives and elderly homes. Corilus, a portfolio company of Gilde Buy Out Partners, has over 40,000 customers, served out of seven locations.

Oaklins’ team in Belgium acted as the sole financial advisor to the sellers in this transaction.

Service

M&A sell-side

Parties

“Oaklins guided me and my team throughout the entire process and advised us on the various aspects of the complex transaction structure. Their financial expertise, market understanding and process management were instrumental in providing us comfort and support, but moreover helped us to keep on top of things and focus on what matters.”

Jeroen De Backer

CEO, Pridiktiv NV

Talk to the deal team

Bart Delusinne

Managing Director

Brussels, Belgium
Oaklins KBC Securities

View profile Get in touch

Alexander Gryson

Director

Brussels, Belgium
Oaklins KBC Securities

View profile Get in touch

Pieter Vanhoudt

Associate Director

Brussels, Belgium
Oaklins KBC Securities

View profile Get in touch

Related deals

Valmiermuižas Alus has been acquired by Cēsu Alus

Private Equity | Food & Beverage

Valmiermuižas Alus has been acquired by Cēsu Alus

Valmiermuižas Alus has been acquired by Cēsu Alus AS through the purchase of 100% of its shares. The transaction enabled the founder’s exit and strengthened the company’s platform for continued growth within a consolidating Baltic beverage market.

Learn more

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland

Healthcare

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland

LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.

Learn more

Armira has signed an agreement to acquire a majority stake in Viabus

Private Equity | Consumer & Retail

Armira has signed an agreement to acquire a majority stake in Viabus

Armira, a Germany-based investment firm, has signed an agreement to acquire a majority stake in Viabus, a leading Dutch tour operator focused on senior and young senior travelers.

Learn more